ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

Biotechnology

Healthcare
$7.65 -0.75%

-$0.07 today

Market cap
$795.08M
Beta
1.06
P/E (TTM)
-6.7
EPS (TTM)
-$1.28
52W Low $7.23High $14.93

Volume 1.39M

Average 1.91M

ORIC Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

ORIC Pharmaceuticals, Inc.NASDAQ: ORIC

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 105.47M shares rose 48.5% year over year, ahead of the +31.1% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 20.1% from the prior quarter. Over 3 fiscal years it compounded at +30.3% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +48.5% holds above the trailing-twelve-month pace of +31.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
105.47M+20.1% QoQ
Last fiscal yearDec 2025
87.79M+25.9% YoY
LTMMar 2026
92.59M+31.1% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+48.5%——
1 year+25.9%——
3-year CAGR+30.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
87.79M USD
Year-over-year change
+25.9%
4-year CAGR
+23.3%

Weighted Avg Shares vs competitors

How ORIC compares with its peers on the latest reported figures

  • ORIC's LTM Mar 2026 weighted avg shares of 92.59M shares is the 2nd highest of the 11 companies compared; the peer median is 64.57M shares.
  • Its year-over-year change of +31.1% is the 2nd highest of 11, against a peer median of +14.2%.
  • Over three fiscal years its annual growth of +30.3% compares with a peer median of +15.3%.
ORIC Competitors Peer median
Weighted Avg Shares for ORIC and competitors
Company Period LTM YoY 3-year CAGR
NUVBNuvation Bio Inc.LTM Jun 2026345.71M +7.2%+16.4%
ORICORIC Pharmaceuticals, Inc.LTM Mar 202692.59M +31.1%+30.3%
SNDXSyndax Pharmaceuticals, Inc.LTM Mar 202686.55M +1.2%+12.5%
CRVSCorvus Pharmaceuticals, Inc.LTM Mar 202682.39M +23.5%+19.3%
VSTMVerastem, Inc.LTM Mar 202680.25M +101.5%+62.5%
ELVNEnliven Therapeutics, Inc.LTM Sep 202665.9M +23.1%+108.5%
MGNXMacroGenics, Inc.LTM Mar 202663.24M +0.8%+0.9%
JANXJanux Therapeutics, Inc.LTM Mar 202662.14M +9.2%+14.3%
TYRATyra Biosciences, Inc.LTM Mar 202660.14M +2.0%+12.5%
AVBPArriVent BioPharma, Inc. Common StockLTM Mar 202640.11M +19.2%+4.7%
NVCTNuvectis Pharma, Inc.LTM Mar 202622.33M +21.4%+19.9%
Peer median (excluding ORIC) 64.57M+14.2%+15.3%

Competitors are the stored peer set for ORIC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue001.03M1.11M1.22M
Gross Profit00(1.03M)(1.11M)(1.22M)
Gross Margin—————
Research & Development56.86M61.68M85.17M114.07M109.82M
Selling, General & Admin22.01M25.09M25.61M28.82M33.19M
Operating Expenses78.87M91.77M109.75M141.79M141.78M
Depreciation & Amortization897K966K1.03M1.11M1.22M
EBITDA(77.82M)(85.8M)(99.67M)(126.74M)(128.25M)
EBITDA Margin—————
Operating Income(78.87M)(91.77M)(110.78M)(142.9M)(143M)
Operating Margin—————
Interest Income141K2.65M10.08M00
Interest Expense02.65M000
Other Income / Expenses156K2.65M10.08M15.05M13.54M
Income Before Tax(78.72M)(89.12M)(100.7M)(127.85M)(129.47M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(78.72M)(89.12M)(100.7M)(127.85M)(129.47M)
Net Margin—————
EPS (Basic)(2.07)(2.25)(1.96)(1.83)(1.47)
EPS (Diluted)(2.07)(2.25)(1.96)(1.83)(1.47)
Weighted Avg Shares37.95M39.66M51.45M69.73M87.79M
Weighted Avg Shares (Diluted)37.95M39.66M51.45M69.73M87.79M

ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

Intrinsic Alpha fair value

Locked

Current Price

$7.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.